The overlap of biologics during medication switches is common in routine care of patients with IBD and isn’t linked to a ...

With the introduction of a subcutaneous formulation, ENTYVIO has expanded patient convenience and global accessibility. Continued growth is supported by rising IBD prevalence and ongoing geographic ...

The use of healthcare services for the long-term management of IBD is less prevalent among historically marginalized racial ...

The startup, affiliated with China-based antibody designer Helixon Therapeutics, is developing bispecific drugs aimed at ...

The Crohn's and Colitis Foundation is committed to finding cures for Crohn's disease and ulcerative colitis as they also work ...

Irritable bowel syndrome (IBS) can mimic some symptoms of inflammatory bowel disease (IBD). Learn how their causes, diagnosis ...

Sanofi is continuing to splash the cash for autoimmune and immunology assets this spring by penning a new deal with ...

Pharma advertisers have kicked off 2025 with a bang, with the top 10 spenders throwing almost 30% more money behind their TV ...